Abnormal expression and clinicopathologic significance of p120-catenin in lung cancer

Histology and Histopathology

Volumn 21, Issue 7-9, 2006, Pages 841-847

  Wang, En Hua ^a   Liu, Y ^a   Xu, H T ^a   Dai, S D ^a   Liu, N ^a   Xie, C Y ^a   Yuan, Xi Ming ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Catenin; Lung cancer; p120ctn; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; CATENIN; ISOPROTEIN; MEMBRANE PROTEIN; PROTEIN P120; CADHERIN ASSOCIATED SRC SUBSTRATE P120; CADHERIN-ASSOCIATED SRC SUBSTRATE P120; CELL ADHESION MOLECULE; PHOSPHOPROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BRONCHUS MUCOSA; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CELL MEMBRANE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LUNG ADENOCARCINOMA; LUNG PARENCHYMA; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; TISSUE LEVEL; TREATMENT OUTCOME; WESTERN BLOTTING; ADENOCARCINOMA; ENZYME IMMUNOASSAY; LUNG; LUNG TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHOSPHOPROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN ISOFORMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 33746168952     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Anastasiadis P.Z and Reynolds A.B. (2000). The p120 catenin family: complex roles in adhesion, singaling and cancer. J. Cell Sci. 113, 1319-1334.
2. Bremmes R.M., Veve R., Gabrielson E., Hirsch F.R., Baron A., Bemis L., Gemmill R.M., Drabkin H.A. and Franklin W.A. (2002). High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J. Clin. Oncol. 20, 2417-2428.
3. Brien T.P., Depowski P.L., Sheehan C.E., Ross J.S. and McKenna B.J. (1998). Prognostic factors in gastric cancer. Mod. Pathol. 11, 870-88.
4. Daniel J.M. and Reynolds A.B. (1999). The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol. Cell Biol. 19, 3614-3623.
5. Herrenknecht K., Ozawa M., Eckerskon C., Lottpeich F., Lenter M. and Kemler R. (1991). The uvomorulin-anchorage protein alpha catenin is a vinculin homologue. proc. Natl. Acad. Sci. USA 88, 9156-9160.
6. ctn. J. Biol. Chem. 276, 28006-28013.
7. Montonen O., Aho M., Uitto J. and Aho S. (2001). Tissue distribution and cell type-specific expression of p120ctn isoforms. J. Histochem. Cytochem. 49, 1487-1496.
8. Nagafuchi A., Takeichi M. and Tsukita S. (1991). The 102 kd cadherin-associated protein: similarity to vinculin and postranscriptional regulation of expression. Cell 65, 849-857.
9. Noren N.K., Liu P.B., Burridge K. and Kreft B. (2000). p120 catenin regulates the actin cytoskeleton via Rho family GTOases. J. Cell Biol. 150, 567-580.
10. Pirinen R.T., Hirvikoski P., Johansson R.T., Hollmen S. and Kosma V.M. (2001). Reduced expression of alpha-catenin, beta-catenin, and gamma-cattenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer. J. Clin. Pathol. 54, 391-395.
11. Qiu X., Yang X., Li Q and Wang E. (2002). A study of E-cadherin and beta-catenin expression and their correlation with prognosis of nonsmall cell lung carcinoma. Zhong hua bing Li xue Za Zhi 31, 318-321.
12. Rimm D.L., Koslov E.R., Kebriaei P., Cianci C.D. and Morrow J.S. (1995). Alpha 1(E)-catenin is an actin-binding and bundling protien mediting the attachment of F-actin to the membrane adhesion complex. Proc. Natl. Acad. Sci. USA 92, 8813-8817.
13. Shibanuma H., Hirano T., Tsuji K., Wu Q., Shrestha B., Konaka C., Ebihara Y. and Kato H. (1998). Influence of E-cadherin dysfunction upon local invasion and metastasis in non-small cell lung cancer. Lung Cancer 22, 85-95.
14. Sarrio D., Perez-Mies B., Hardisson D., Moreno-Bueno G., Suarez A., Cano A., Martín-Pérez J., Gamallo C. and Palacios J. (2004). Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobulr breast carcinoma from preinvasive to metastatic lesions. Oncogene 23, 3272-3283.
15. Shibanuma H., Hirano t., Tsuji K., Wu Q., Shrestha B., Konaka C., Ebihara Y. and Kato H. (1998). Influence of E-cadherin dysfunction upon local invasion and metastasis in non-small cell lung cancer. Lung Cancer 22, 85-95.
16. Smythe W.R., Williams J.P., Wheelock M.J., Johnson K.R., Kaiser L.R. and Albelda S.M. (1999). Cadherin and catenin expression in normal bronchial epithelium and non-small cell lung cancer. Lung Cancer 24, 157-168.
17. Thoreson M.A. and Reynolds A.B. (2002). Altered expression of the catenin p120 in human cancer: implications for tumor progression. Differentiation 70, 583-589.
18. Thoreson M.A., Anastasiadis P.Z., Daniel J.M., Ireton R.C., Wheelock M.J., Johnson K.R., Hummingbird D.K. and Reynolds A.B. (2000). Selective uncoupling of p120(ctn) from E-cadherin disrupts strong adhesion. J. Cell Biol. 148, 189-202.
19. Travis W.D., Brambilla E., Muller-Hermelink H.K. and Harris C.C. (Eds). (2004). Wolrd Health Organization Classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC Press Lyon.
20. Watanabe Y. (2003). TNM classification for lung cancer. Ann. Thorac. Cardiovasc. Surg. 9, 343-350.
21. ctn. J. Cell Biol. 141, 779-789.